Page 28 - Anne Donohoe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. atai Life Sciences to Present at the Cowen Psychedelics & Novel Mechanisms in . atai Life SciencesJuly 7, 2021 GMT BERLIN, Germany, July 07, 2021 (GLOBE NEWSWIRE) atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company developing psychedelic and non-psychedelic compounds for various mental health indications, today announced that it will present and participate in one-on-one investor meetings at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit on July 13, 2021. Presentation details can be found below. Date: ADVERTISEMENT A replay of the presentation will be available in the “Events” section of the atai Life Sciences website at ir.atai.life.

New yorkUnited statesAnne donohoeExchange commissionStrategic communicationsLife sciencesnv nasdaqLife sciencesCowen psychedelicsNovel mechanismsNeuropsychiatry summitPrivate securities litigation reform actChief financial officerபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்அன்னே தொனொோேபரிமாற்றம் தரகு